The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
ME Research UK
a/k/a: MER UK
North Methven Street
Perth, PH1 5PP
The ME Research UK is a non-profit organization whose principal aim is to commission and fund scientific investigation into the causes, consequences and treatment of myalgic encephalomyelitis/chronic fatigue syndrome (also known as ME/CFS). This syndrome is a debilitating illness characterized by excessive fatigue that does not respond to bed rest. It affects around 1 million people in the USA, and 200,000 people in the UK, but is not well understood nor, in many cases, properly recognized. The charity also has a mission to "Energize ME Research", which involves raising awareness of the need for biomedical research into ME/CFS globally, providing high quality information on all aspects the of illness for a wide range of audiences, and hosting conferences on ME/CFS biomedical research.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.